Drug Type Monoclonal antibody |
Synonyms Opucolimab, 重组抗PD-L1全人单克隆抗体 (上海复宏汉霖生物), HLX-20 |
Target |
Mechanism PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 2 | CN | 30 Jan 2023 | |
Advanced Malignant Solid Neoplasm | Phase 1 | AU | 07 Aug 2018 | |
Neoplasms | IND Application | CN | 13 Feb 2018 |